The global thrombectomy device market was valued at $1,269.0 million in 2020, and is projected to reach $2,567.5 million by 2030, registering a CAGR of 7.4% from 2021 to 2030. Thrombectomy device is used to treat blood clots, which are present in capillaries, veins, and arteries. Surgical thrombectomy is a procedure, which removes blood clot from an artery or vein that obstructs blood flow. Thrombectomy devices minimize the damage that can be caused to blood vessels during procedure and reduce blood loss. These devices are available according to affected areas, in different sizes, and diameters. These devices are used to treat acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.
The key factors that drive the market growth include, increase in incidence of cardiovascular disease, rise in unhealthy living conditions and habits in young generation, and surge in geriatric population. Increase in incidence of neurological disorder, surge in demand for minimally invasive procedures, development of healthcare infrastructure, and rise in competition among key player for development of thrombectomy device propel the growth of the market. In addition, increase in technological advancements and innovations for development of advanced thrombectomy device surge the growth of the market.
Thrombectomy devices market is segmented on the basis of technology, type, utility, disease, and region. Depending on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. By type, it is divided into automated devices and manual devices. According to utility, it is bifurcated into reusable devices and disposable devices. As per disease, it is categorized into peripheral diseases, coronary diseases, and neural diseases
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include AngioDynamics, Inc., Johnson & Johnson, Inc., Penumbra Inc., Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc., Stryker Corporation, and Teleflex Incorporated
The key factors that drive the market growth include, increase in incidence of cardiovascular disease, rise in unhealthy living conditions and habits in young generation, and surge in geriatric population. Increase in incidence of neurological disorder, surge in demand for minimally invasive procedures, development of healthcare infrastructure, and rise in competition among key player for development of thrombectomy device propel the growth of the market. In addition, increase in technological advancements and innovations for development of advanced thrombectomy device surge the growth of the market.
Thrombectomy devices market is segmented on the basis of technology, type, utility, disease, and region. Depending on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. By type, it is divided into automated devices and manual devices. According to utility, it is bifurcated into reusable devices and disposable devices. As per disease, it is categorized into peripheral diseases, coronary diseases, and neural diseases
Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in this report include AngioDynamics, Inc., Johnson & Johnson, Inc., Penumbra Inc., Terumo Corporation, Abbott, Boston Scientific Corporation, Medtronic plc., Stryker Corporation, and Teleflex Incorporated
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the thrombectomy devices market analysis from 2020 to 2030 to identify the prevailing thrombectomy devices market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the thrombectomy devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global thrombectomy devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Technology
- Mechanical Thrombectomy
- Aspiration Thrombectomy
- Rheolytic Thrombectomy
By Type
- Automated Devices
- Manual Devices
By Utility
- Reusable Devices
- Disposable Devices
By Application
- Peripheral Diseases
- Coronary Disease
- Neural Diseases
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Australia
- Rest Of Asia Pacific
- China
- Japan
- India
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbott Laboratories
- AngioDynamics, Inc
- Boston Scientific Group
- Johnson and Johnson
- Koninklijke Philips N.V.
- Medtronic plc
- Penumbra Inc.
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY
CHAPTER 5: THROMBECTOMY DEVICES MARKET, BY TYPE
CHAPTER 6: THROMBECTOMY DEVICES MARKET, BY UTILITY
CHAPTER 7: THROMBECTOMY DEVICES MARKET, BY APPLICATION
CHAPTER 8: THROMBECTOMY DEVICES MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Thrombectomy Devices Market,' the thrombectomy devices market size was valued at $1.3 billion in 2020, and is estimated to reach $2.6 billion by 2030, growing at a CAGR of 7.4% from 2021 to 2030. Thrombectomy devices assist surgeons to remove blood clot from veins or arteries of the patient. These devices are efficient in treating blood clots in veins and arteries compared to other methods of clot management.High occurrence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE) and rise in sedentary and unhealthy lifestyle drives the thrombectomy devices market growth. In addition, rise in healthcare infrastructure, increase in demand for minimally-invasive treatments, surge in geriatric population, growth in competition among key players, and technological advancements & innovations drive the thrombectomy devices market trends. For instance, in September 2021, Abbott, a pharmaceutical company, announced the acquisition of maker walk vascular, which is the mechanical thrombectomy device. Walk vascular offers JETi peripheral systems that helps to remove intravascular clots called a thrombus, which may minimize blood flow and lead to serious complications for patients. Moreover, in June 2021, AngioDynamics, a medical technology company, announced the U.S. Food and Drug Administration (FDA) clearance for alphaVac mechanical thrombectomy system, which is an off-circuit, multi-purpose mechanical aspiration thrombectomy device. It is used for the non-surgical removal of thrombi or emboli from the vasculature. Thus, increase in number of approval for thrombectomy devices, and increase in demand for thrombectomy device, surge the growth of thrombectomy devices industry. Unavailability of trained professionals, lack of awareness about thrombectomy devices, and complicated use of thrombectomy devices hinder the growth of the thrombectomy devices market share.
Thrombectomy devices market is segmented on the basis of technology, type, utility, application, and region. Depending on technology, it is categorized into mechanical thrombectomy devices, aspiration thrombectomy devices, and rheolytic thrombectomy devices. According to type, it is divided into automated devices and manual devices. As per the utility, it is bifurcated into reusable devices and disposable devices. By application, it is categorized into peripheral diseases, coronary diseases, and neural diseases. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region-wise, North America dominated the thrombectomy device market in 2020, and is expected to be dominant during the forecast period, owing to growth in advanced health care facility, rise in prevalence of neurological disorder, increase in number of approvals for thrombectomy devices, surge in number of surgical procedures, and rise in presence of key players in thrombectomy devices industry. However, Asia-Pacific is expected to register highest CAGR of 8.8% from 2021 to 2030, owing to growth in patient population, increase in government insurance coverage in developing countries, increase in prevelnce of cardiovascular disesaes and rise in approvals of new innovative embolization and mechanical thrombectomy products.
The COVID-19 outbreak negatively impacted the thrombectomy device market. The COVID-19 pandemic hampered healthcare systems across the globe. Surgical procedures are affected by COVID-19 pandemic. Several clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to COVID-19 outbreak declined the number of elective surgeries performed across the globe.
Key findings of the Study
- By technology, the mechanical thrombectomy device segment was the highest contributor to the market in 2020.
- On the basis of type, the manual thrombectomy device segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- On the basis of utility, the disposable thrombectomy device segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- On the basis of application, neural disease segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- Region-wise, North America garnered the largest revenue share in 2020. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Abbott Laboratories
- AngioDynamics, Inc
- Boston Scientific Group
- Johnson and Johnson
- Koninklijke Philips N.V.
- Medtronic plc
- Penumbra Inc.
- Stryker Corporation
- Teleflex Incorporated
- Terumo Corporation
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 115 |
| Published | April 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 1269 million |
| Forecasted Market Value ( USD | $ 2567.5 million |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
